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Extensive  studies  have  established  that  the  major  histocompatibility  complex 
(MHC) 1 is the main  barrier to the transplantation  of skin  and  bone marrow. The 
analyses with organ allografts have been less detailed, although, at least with kidney 
grafts, the available evidence definitely supports a  major role for the MHC  in the 
primary rejection response. Thus, in the rat, primary kidney graft rejection is weak or 
nondetectable where donor and recipient strains are matched for the MHC  (1), and 
three studies using a segregating backcross population as kidney donors showed that 
acute  rejection occurred only in  MHC-mismatched  combinations  (2,  3).  In  other 
species,  including  the  dog  (4),  the  rhesus  monkey  (5),  and  man  (6),  the  rejection 
response to kidney grafts from MHC-identical siblings is relatively weak. 
Kidney-specific antigens have been invoked frequently as potentially important in 
graft rejection (7-13), but the evidence has never been strong. Such responses could 
conceivably be  directed  at  kidney-specific alloantigens  coded  for either within  or 
outside the MHC or at kidney-specific autoantigens. There is evidence for skin-specific 
alloantigens coded for by loci outside the MHC in both the mouse (14,  15) and the 
rat (16).  However most of our understanding of transplantation antigens is based on 
serological analyses using lymphocyte or erythrocyte (RBC)  targets.  Tissue-specific 
antibodies have thereby been largely excluded from analysis, and it is perhaps for this 
reason that most polymorphisms of cell membrane molecules have been described on 
lymphocytes and  RBC  (17).  Therfore we  develooped an  125I-anti-Ig  binding  assay 
using kidney homogenate as the target tissue (18). By using, as the target in serological 
analysis, the same tissue used in the immunization of the host, the full spectrum of 
antibodies can be studied, and  the presence or absence of tissue-specific antibodies 
can be established unequivocally. 
In  a  previous study  (18), we  showed that  -80%  of the  antibodies  produced  by 
immunizing LEW rats with DA kidney homogenate are directed at kidney-specific 
antigens:  about one-half at a  kidney-specific autoantigen, and one-half at a  kidney- 
specific alloantigen  (18). In  this paper, we have characterized the alloantigen, and 
studied its production after kidney transplantation and its role in graft rejection. 
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United Kingdom, and the Wellcome  Trust. 
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Materials  and  Methods 
Animals.  Inbred LEW (RT11) and DA (RT1 a) rats were bred and maintained at the animal 
house of the  Radcliffe Infirmary, Oxford,  England.  Inbred  Fischer (RTll),  AGUS  (RTII), 
PVG/c (RTI~), and WAG (RT1 u) were obtained from Bantin and Kingman Ltd., Grimston, 
Aldborough, Near Hull, Yorkshire, England. Inbred AS (RT1 l) and August (RT1 e) rats were 
from the McIndoe Research Unit, Sussex, England, and inbred BN (RTI") rats were from St. 
Mary's Hospital, London, England. Outbred Sprague-Dawley and Wistar rats, rabbits and a 
Dunkin  Hartley guinea pig were from  the Radcliffe Infirmary animal house.  All rats were 
young adults from 10 to 30 wk of age. 
Kidney Transplantation.  Left orthotopic grafts were performed essentially as previously de- 
scribed (19) using microsurgical techniques for end-to-end anastomosis of the renal vessels and 
ureter. All ischemia times were <30 min.  Right nephrectomy was performed at  day 7,  and 
graft function was assessed by serial blood ureas and by animal survival. 
Homogenates.  Kidneys, hearts, livers, and spleens were removed from freshely exsanguinated 
animals and homogenizedd either immediately, or after storing at -40°C. All procedures were 
at 4°C or on ice. Homogenates were prepared by mincing in phosphate-buffered saline (PBS) 
(Dulbeeco's A and B, Oxoid Ltd., London, England) using mechanically driven blades, followed 
by  mechanical  homogenization  using  a  Teflon  pestle  and  then  by  manual  ground-glass 
homogenization.  Large  particles  were  removed  by  centrifuging  at  40  g  for  1  min.  The 
homogenate was then washed twice in PBS by centrifuging at 35,000 g for 20 min. The second 
pellet was resuspended in an equal volume of PBS by manual ground-glass homogenization, 
aliquoted, and stored at -40°C. The protein content of the homogenates was estimated by a 
modification of the  method  of Lowry et  al.  (20),  using bovine serum  albumin  (BSA)  as a 
standard, and was generally in the range of 20-40 mg/ml. 
Cell Suspensions.  All cell suspensions were  in  0.5%  BSA  (Sigma Chemical Co.,  London, 
England)  in  PBS.  Single cell suspensions were  prepared  from  thymuses  by  pressing them 
through a  metal sieve. Contaminating RBC were removed by incubation with Tris-buffered 
ammonium  chloride (21).  Viability was assessed by trypan  blue exclusion and  was almost 
always >80%.  RBC were prepared by two sequential centrifugations with removal of buffy 
coat and upper RBC layer each each time, followed by centrifugation over Triosil (Nyegaard, 
Oslo, Norway) -Ficoll (Pharmacia Fine Chemicals, Inc., Uppsala, Sweden) of specific gravity 
1.090  to remove residual leukocytes. All cell counts were performed on  a  Coulter Counter, 
model DN (Coulter Electronics, Harpenden, Herts, England). 
Antisera 
LEw ANTI-DA  KIDNEY GRAFT  SERUM.  A LEW rat was given a left orthotopic DA kidney graft 
as described above, except that  the recipient's right kidney was not removed. At 4 wk,  the 
rejected graft was removed and replaced with a fresh DA graft, to obtain a second-set response. 
The rat was bled on days 7, 9,  11,  13, and  15 and exsanguinated on day  17 after the second 
kidney graft. Sera from all bleeds were pooled, aliquoted, and stored at -40°C. 
LEW ANTI-DA  KIDNEY HOMOGENATE SERUM.  This was prepared using DA kidney homogenate 
in  the  following schedule.  Five LEW  male rats were immunized with  1 mg of DA kidney 
homogenate protein (prepared from perfused male kidneys) emulsified in an equal volume (0.1 
ml) of complete Freund's adjuvant and injected subcutaneously into the hind footpads. Boosts 
as above but in incomplete Freund's adjuvant were given on weeks 4, 7, and  11. The animals 
were bled by cardiac puncture three times during week 8 and twice during week 12, and were 
exsanguinated at  week  13.  All sera were pooled, heat  inactivated, aliquoted, and  stored at 
-40°C. 
DA ANTI-LEW  KIDNEY HOMOGENATE SERUM.  This was from pooled bleeds of DA rats after 
immunization with LEW kidney homogenate in adjuvant on weeks 0, 4, and  7, as described 
above. 
IMMUNOADSORBENT-PURIFIED  RABBIT F  (ABt)2  AND ANTI-RAT F(ABP)2 (RAR).  This was prepared, 
iodinated, and fluorescein labeled as described previously (18). 
Binding Assay.  This was performed essentially as described by Morris and Williams (22), 
except that homogenate and not a single cell suspension was used on the target. All procedures 
were at 4°C or on ice. Kidney homogenate to be used as target was thawed, diluted ~ 10-fold D.  N. J.  HART AND JOHN  W.  FABRE  653 
in PBS,  spun at  1,500 g  for  15  min, and the pellet was  resuspended to  2  mg homogenate 
protein/mi in 0.5% BSA/PBS. Virtually all of the homogenate protein was recovered in this 
pellet. 
Duplicate 25-#! samples of sera to be asayed were transferred to LP3 tubes (Luckham Ltd, 
Burgess  Hill, Sussex,  England). If the sera had been used in absorption analysis, they were 
prespun at 6,000 g for 5 min immediately before assay. 25 #1 of target homogenate suspension 
was added to each tube, and this was incubated for 1 h on ice. The target homogenate was then 
washed twice by spinning at 1,500 g for 15 min and 100 #1 of RAR at 25 #g/ml in 0.5% BSA/ 
PBS with a trace Of ~2nI-labeled RAR (~400,000 cpm per assay tube) was added to the pellet 
of the second wash. After resuspension, the homogenate was incubated for an additional 1 h on 
ice and washed twice as above. The pellet of the second wash was resuspended in 0.5 ml PBS, 
transferred to fresh LP3 tubes, and the homogenate-bound  radioactivity measured on a Packard 
gamma counter (Packard Instrument Co., Downers Grove, Ill.) The results are expressed  as 
nanograms of RAR bound per assay,  which can be calculated, assuming that  labeled and 
unlabeled RAR bind equally well. In one analysis, 125I-RAR was used alone, without unlabeled 
RAR, to increase sensitivity (22) and in this case, the results are expressed  as counts per minute 
bound per assay. 
Absorption Analysis.  Initial titrations of the sera were performed to choose a dilution which 
represented conditions of target  antigen excess  in the assay system. Absorptions were then 
performed at this serum dilution, by incubating  the serum with equal volumes (80 #1) of tripling 
dilutions of homogenates or cell suspensions in 0.5% BSA/PBS. Again, all procedures were 
performed at 4°C or on ice. Absorbing tissue was removed by centrifugation and the absorbed 
serum stored at -40°C until all the absorptions for a particular analysis had been completed. 
For the absorption, homogenates were used at starting concentrations as prepared above, 
i.e., ~50% solid tissue.  The alignment of the absorption curves for homogenates was done on 
the basis of protein content. On this basis, the starting concentration of the homogenates was 
approximately equivalent to lymphocytes at 109/ml (23). 
Exhaustive absorptions were performed by absorbing with the pellet after centrifugation (to 
avoid antiserum dilution) of an equal volume of homogenate or cell suspension at the starting 
concentration. After  spinning down  the  homogenate or  cells,  the  preabsorbed  serum  was 
absorbed quantitatively as described above. 
Lymphocytotoxicity Assay.  This was a  two-stage SlCr-release  assay  using blood lymphocyte 
targets and guinea pig serum as the source of complement. 2 #1 of doubling dilutions of serum 
were mixed with 2 #1 of nlcr-labeled lymphocytes at 2 ×  10S/ml and incubated at 20°C for 30 
min in humidified Terasaki plates (humidified microtest plates; Falcon Labware, Div. of Becton 
Dickinson & Co., Oxnard, Calif.). 5 #1 of guinea pig serum was then added, and the plates were 
incubated for a  further 60  min at  20°C. At the end of this incubation, the cells were spun 
down, and the radioactivity of the supernate was measured in a Packard gamma counter. 
Backcross Analysis.  20 LEW ×  (DA ×  LEW)F1 backcross rats underwent right nephrectomy. 
Each  kidney was  immediately cooled  in  ice-cold  PBS,  and  individually homogenized  as 
described above. The kidneys were used in absorption analyses to detect three antigens: (a) 
RT1-A  a (i.e., DA SD-type antigens) using LEW anti-DA spleen serum assayed on DA RBC 
targets;  (b)  RT1-B  a (i.e.,  DA Ia-type antigens) using exhaustively DA-RBC-absorbed LEW 
anti-DA spleen sera assayed on thymocytes; and (c) the DA allele of the kidney-specific antigen 
system using LEW-kidney- and DA-splecn-absorbed LEW anti-DA kidney homogenate serum 
assayed on DA kidney homogenate.The specificity of the assays for the RT1-A  a and RT1-B  a 
antigens has been carefully established previously (24), and the same sera were used in this 
study. 
Immunofluorescense.  Cryostat-cut sections of frozen kidney were  transferred to  gelatinized 
slides, dried for 15 min at 4°C, and washed once with PBS.  All subsequent procedures were 
carried out at room temperature. The sections were incubated for 30 rain with unlabeled RAR 
at 100/~g/ml to block any immunoglobulins  present, and washed three times by incubating for 
10 rain with PBS. Test sera were added to the sections for 30 min, and the sections were washed 
three times. Fluorescein-labeled RAR at  50/xg/ml was added  for  30  min, and the sections 
again washed  three times. They were  then mounted in 90%  vol/vol glycerine in PBS,  and 
examined with a Leitz Ortholux II microscope (E. Leitz, Inc., Rockleigh, N. J.). 654  A  KIDNEY-SPECIFIC  ALLOANTIGEN  IN  THE  RAT 
Results 
Analysis  of Alloantibodies After  Removal of Autoantibody Component.  In  our  previous 
analysis of the LEW anti-DA kidney homogenate serum, >50% of the antibodies were 
found to be directed at autoantigens  (18).  To begin with we therefore examined the 
LEW anti-DA kidney graft serum  for autoantibodies,  by absorbing the serum with 
LEW  kidney  and  assaying  on  DA  kidney  homogenate.  The  serum  did  contain 
autoantibodies  but  the amount  was, as expected,  less than  in  the anti-homogenate 
serum prepared with adjuvants. 
Both  the anti-graft and anti-homogenate serum were absorbed exhaustively with 
LEW kidney to remove autoantibodies and then reanalyzed. The results are given in 
Fig.  1 A  and  B.  It  can  be  seen  that  the  removal  of autoantibodies  was  complete 
because in both sera, LEW kidney failed to absorb any further antibody. Absorption 
with DA spleen  homogenate clearly subdivided  the alloantibodies into  two compo- 
nents, one present on both kidney and spleen (almost certainly the DA MHC antigens) 
and  another present  on  kidney  but  absent  from spleen.  From  the point  of view of 
transplantation,  it  is  of interest  that  this  component  was  produced  after  kidney 
allografting, as well as after immunization with homogenate. 
The specificity absent  from spleen  was studied  by exhaustively preabsorbing the 
LEW and anti-DA kidney homgenate serum with LEW kidney and DA spleen before 
further quantitative  absorptions. The results  are given in  Fig.  2 and  show that  the 
alloantigen  absent  from  spleen  is  also  absent  from  heart  and  liver,  and  we  have 
therefore  designated  it  as  kidney specific.  Because  the  kidney-specific antigen  was 
more easily characterized by the stronger anti-homogenate serum, this serum was used 
in most subsequent studies. 
Genetic Linkage of the Gene Coding for the Kidney-specific Antigen.  Whether or not  the 
gene coding for the kidney-specific alloantigen was linked to the rat MHC was tested 
by typing the kidneys of 20 LEW ×  (DA ×  LEW)F1 backcross animals as outlined in 
Materials  and  Methods.  Both  the  SD  and  Ia antigens  of the  MHC  were  typed  in 
addition  to the kidney-specific alloantigen, and the results are given in Fig. 3. It can 
be seen from Fig. 3 A that the kidneys could be divided into two distinct groups; 5 of 
the 20 kidneys were able to absorb out the kidney-specific alioantibodies, and therefore 
they were typed positive for the antigen. It is clear that only one kidney-specific locus 
was being studied (X  z for two loci was 24.1, P <  0.001). Indeed, the number of positive 
kidneys was sufficiently small  to raise the  possibility that  more than  one gene was 
necessary for the expression of the antigen (X  2 = 4.1, P ~  0.05).  Fig. 3 B and C shows 
that 8 of the 20 kidneys typed positively for the DA MHC antigens, and as expected 
from the low recombination frequency between the SD and Ia loci, the 8 animals that 
were positive for the SD antigens were the same that were positive for the Ia antigens. 
Of the kidneys which typed positively for the DA kidney alloantigen (closed symbols), 
four were not associated with the DA MHC, and one was. It is clear, therefore, that 
there is no genetic linkage between the gene(s) coding for the kidney-specific alloan- 
tigen and the MHC. 
Strain and Species Distribution of the DA Kidney-specific Alloantigen  Kidneys of all the 
strains depicted in Table I were homogenized and typed by absorption as described 
in  the  backcross studies.  The results  show  that  most of the  strains  carried  the  DA 
allele of the kidney-specific alloantigen system, the exceptions were the AS and LEW 
strains.  The species cross-reactivity of the specificity was tested  by absorption  with D.  N. ,J.  HART  AND `JOHN  W.  FABRE  655 
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FIG.  1.  Allospe¢ificities recognized by LEW anti-DA kidney sera. LEW anti-DA kidney homoge- 
nate serum at a  1/10 dilution (A) and LEW anti-DA kidney graft serum at a  1/4 dilution (B), both 
preabsorbed with LEW kidney homogenate to remove autoantibodies, were absorbed with LEW 
kidney (VI); DA kidney (I---i);  DA kidney ×  2 (m-i);  DA spleen (&) and DA spleen X 2 (A). 
DA kidney homogenate was used as the target tissue. Designation "× 2" indicates that the serum 
had been preabsorbed with the pellet after centrifugation  (to avoid serum dilution)  of an equal 
volume of the tissue indicated before the quantitative absorption shown. 656  A  KIDNEY-SPECIFIC  ALLOANTIGEN  IN  THE  RAT 
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FIG.  2.  Demonstration of kidney-specific alloantigen. LEW anti-DA kidney homogenate serum at 
a  1/10 dilution, preabsorbed with LEW kidney and DA spleen, absorbed with DA spleen (&);  DA 
heart (©);  DA liver (A); and DA kidney ×  2 (m). DA kidney homogenate was used as the target 
tissue. Designation "× 2" as in Fig.  1. 
kidney homogenates from guinea pig, rabbit, dog, and man, and the results are given 
in  Fig.  4.  Rabbit,  dog, and  human  kidneys all  showed substantial  cross-reactivity, 
although  the  absorptive capacities  of these  kidneys was  only  10-30%  that  of DA 
kidney.  Exhaustive  absorptions  were  not  performed, but  dog  kidney  appeared  to 
absorb to a plateau, suggesting that there was a dog-rat cross-reactive component of 
the antibodies,  and  another reacting with rat  but  not  dog. The guinea pig kidney 
tested showed no absorption. 
Localization of the Kidney-specific Alloantigen.  This was done by incubating the LEW- 
kidney-  and  DA-spleen-absorbed  LEW  anti-DA  kidney  homogenate  serum  with 
freshly frozen sections  of DA  kidney,  followed by an  incubation  with  fluorescein- 
labeled  RAR,  as  outlined  in  Materials  and  Methods.  LEW kidney was  used  as  a 
control, and showed no staining Other than faint, granular staining of some glomeruli. 
With DA kidney there was a striking linear staining of tubular basement membranes 
as  shown  in  Fig.  5A.  Not  all  tubular  basement  membranes  were stained,  and  it 
seemed that it was only the proximal convoluted tubules that were positive. Glomeruli 
were almost  always negative, though occasionally a  part  of Bowman's capsule was D.  N.  J.  HART  AND  JOHN  W.  FABRE  657 
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Fxo.  3.  Typing of 20 LEW ×  (DA ×  LEW) Fl backcross rats for the DA MHC and the DA allele 
of the kidney-specific antigen. Right  kidneys from each rat  were  individually homogenized and 
used for absorption at no dilution and a  1/3 dilution of assays for (A) the DA allele of the kidney 
antigen; (B) DA SD (RT1-A') antigens; and (C) DA Ia (RT1-B  a) antigens. For details, see Materials 
and Methods. Rats typing positively for the DA allele of the kidney antigen are represented with 
closed symbols. 
TABLE I 
Strain Distribution of the DA Allele of the Kidney-specific Alloantigen System 
DA  allele  of 
Strain  RTI type  kidney-specific 
system 
LEW  1  - 
AS  1  - 
AGUS  1  + 
Fischer  1  + 
WAG  ~  + 
PVG/C  c  + 
August  c  + 
BN  n  + 
DA  a  + 
Wistar (not inbred colony)  + 
Sprague-Dawley (not inbred colony)  + 
positive, as shown in Fig.  5 B. The vasculature was completely negative, as was the 
kidney medulla; there was a very sharp cutoffof fluorescence at the cortico-medullary 
junction. 
To be certain that the binding assay and the fluorescence studies were detecting 
the same antigen,  biopsies  from four kidney-antigen-positive backcrosses and  from 
three kidney-antigen-negative backcrosses were tested for the tubular basement mem- 
brane  antigen  in  fluorescence  studies  as  above.  All  four  kidney-antigen-positive 658  A  KIDNEY-SPECIFIC  ALLOANTIGEN  IN  THE  RAT 
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FIo.  4.  Species cross-reactivity for the  DA allele of the kidney-specific antigen. LEW anti-DA 
kidney homogenate serum at a  1/10 dilution exhaustively preabsorbed with LEW kidney and DA 
spleen, was absorbed quantitatively with kidney homogenate of LEW rat (F-I); DA rat (I); guinea 
pig (&); dog ((9); rabbit (A); and human (O). DA kidney was used as the target tissue. 
backcrosses (so designated by absorption analysis) gave strong staining of the tubular 
basement membrane, whereas all three kidney-antigen-negative backcrosses had no 
staining at all. 
DA lung tissue did not show basement membrane staining with the LEW and DA 
kidney alloantigen serum. 
Role of the Kidney-specific Alloantigen in Kidney Allografl Rejection.  This was tested by 
transplanting the left kidneys from the LEW ×  (DA ×  LEW) backcrosses depicted in 
Fig. 3, into LEW recipients. There were three groups. First, a group where the donors 
had the LEW/LEW MHC genotype and were negative for the kidney alloantigen 
(group  1),  this  group  controlling for the  effects of minor histocompatibility locus 
mismatching. Second, a  donor group that had the LEW/LEW MHC genotype but 
was positive for the kidney alloantigen  (group  2),  to see if incompatibility for the 
kidney alloantigen could induce rejection. Finally, a group with the DA/LEW MHC 
genotype but negative for the kidney antigen were used as donors (group 3) to see if 
the absence of incompatibility for the kidney antigen influenced acute rejection. The D.  N.  j.  HART  AND JOHN  W.  FABRE  659 
FIG.  5.  Localization  of kidney-specific alloantigen.  Cryostat-cut  sections of freshly  frozen  DA 
kidney were incubated first with LEW anti-DA kidney homogenate serum at  1/10  (preabsorbed 
exhaustively with LEW kidney and DA spleen) and then with fluorescein-labeled RAR at 50/Lg/ 
ml. (A) X  125. (B) ×  500. Control sections of LEW kidney had very little background staining, and 
no staining at all of the basement membranes. 660  A KIDNEY-SPECIFIC  ALLOANTIGEN  IN THE RAT 
TABLE II 
Transplantation of LEW × (DA × LEW) Ft Backcross Kidneys into LEW Recipients 
Kidney donor incompati- 
bilities  Mean ± SD of blood urea at week 
Minor  Donor  Kid-  histo-  Survival  group 
ney al-  compat-  1.5  2  4  12 
MHC  loanti-  ibility 
gen  anti- 
gens 
mg/lO0 ml  d 
1  -  --  +  57± 19  48± 17  51±9  41 :l:5  47*,  >100 (four rats) 
2  -  +  +  50± 12  42±7  55±4  54+8  >100 (four rats) 
3  +  --  +  578 ±  78  --  --  --  10, 11, 12, 12, 13 
* This rat died with normal blood urea and normal kidney histology. Cause of death was pneumonia. 
results of post-graft blood ureas and animal survival are given in Table II. There are 
several  points  to note.  First,  mismatching  for the  kidney antigen  (group  2)  did not 
influence graft function or survival.  Second, the absence of a  kidney-antigefi incom- 
patibility  did not appear to influence the rejection of MHC-mismatched  grafts:  the 
rejection  times  in  group  3  are  not  different  from those  of (DA ×  LEW)F1 kidneys 
transplanted  to LEW rats,  where there are incompatibilities  for both the MHC  and 
the kidney antigens (25). Third, it is clear that only the MHC influences first-set graft 
rejection because all nine MHC-matched grafts had no rejection episodes, whereas all 
five MHC-mismatched grafts had fatal acute rejection. 
All of the rats of groups  1 and 2 of Table II underwent  graft biopsy at  day 7 and 
graft  nephrectomy at  ~100  d  after  grafting.  This  was done  to look for histological 
differences between  the two groups especially as regards tubular changes and inter- 
stitial inflammation.  However, there were no obvious differences between the groups 
on  routine  light  microscopy,  the  only  abnormalities  were  mild  mononuclear  cell 
infiltration  and mild edema. 
At the time of graft nephrectomy, the four animals in group 2 were regrafted using 
backcross rats  with  the LEW/LEW  genotype and  that were positive  for the kidney 
antigen  as kidney donors.  This was done to see if transplantation  in  the  face of an 
ongoing response to the kidney antigen  might give rise to a  more vigorous rejection 
response.  However,  the post-graft  course of these animals  as regards  graft  function, 
histology of 7-day biopsy, and survival was the same as the first set of grafts.  These 
animals are now at  100 d  after their second graft, and have normal blood ureas and 
urine volumes. More detailed tubular function studies are in progress. 
Lymphocytotoxicity studies  showed  that  only  the  animals  mismatched  for  the 
MHC produced a significant antibody response to the graft (median titer  1/32, range 
1/4  to  1/128).  Of the  9  animals  grafted  with  MHC-matched  kidneys,  6  had  no 
detectable  antibody at  all,  whereas  the other  three  had  titers  of 1/1,  and  1/1,  and 
1/2. 
Irnmunogenicity of the  Kidney-specific  Alloantigen  in  Kidney Allografls.  That  a  kidney- 
specific response was generated in response to a DA kidney allograft in LEW recipients 
(Fig.  2B)  shows  that  the  kidney-specific  alloantigen  can  induce  a  measureable 
antibody response in the transplant  situation.  However, it  is possible  that  an MHC D.  N. J.  HART AND JOHN W.  FABRE  661 
ng RAR 
BOUND 
260 
240 
220 
200 
180 
160 
140 
120 
•  O~  0 
....--O 
m 
J  I  ;  I  I  I  I  I 
1  2  3  4  6  8  10  12 
WEEKS POST GRAFT 
FIG. 6.  Production of antibodies to the kidney antigen after grafting. Undiluted sera from LEW 
recipients of kidney-antigen-positive kidneys (group  2,  Table  II)  and  kidney-antigen-negative 
kidneys (group  1, Table II)  were tested for binding  to kidney homogenates from LEW/LEW, 
kidney-antigen-positive targets  (group  2,  O)  and  LEW/LEW, kidney-antigen-negative targets 
(group 1, A; group 2, I-1). Points represent mean of the four or five rats in each group. 
incompatibility  is  necessary,  in  addition  to  the  kidney  antigen  incompatibility,  to 
obtain  an antibody response  to the  kidney antigen.  Such adjuvant  effects of MHC 
incompatibilities  have been described  (26) and if they are important  in this case, the 
animals  in  group  2  of Table  II might  not  be  producing  antibodies  to  the  kidney 
alloantigen,  and  therefore  the  conclusion  about  the  lack  of importance  of kidney 
alloantigen in graft rejection might be wrong. 
This was tested  in two ways.  First,  the post-graft sera of the animals  in groups  1 
and 2 of Table II were tested for binding to pooled backcross kidney homogenates of 
(a) kidney-antigen-negative and (b) kidney-antigen-positive animals (both groups were 
of  the  LEW/LEW  MHC  genotype).  The  results  of  these  binding  assays  using 
undiluted sera are given in Fig. 6. The background binding with undiluted serum is 
high, but nevertheless  it can be seen that the rats of group 2 gave higher binding to 
the kidney-antigen-positive kidney homogenate, and that  this was not seen with the 
rats of group  1. Second, the  2- and 3-wk, post-graft sera of the animals  in groups  1 
and  2 were tested  on frozen sections of DA kidney by immunofluorescence.  All the 662  A KIDNEY-SPECIFIC ALLOANTIGEN IN THE RAT 
animals of group 2 but none of the animals of group 1 gave positive staining, and the 
picture was exactly the same as that seen in Fig. 5, except that the staining was a little 
less intense. 
Access of Kidney-specific Alloantibody to Target Antigen in Kidney Grafts.  If the antibody 
is to damage the graft, it is clear that it must have access in vivo to the target antigens. 
This was tested by taking the kidneys of animals in group 2 of Table II at  100 d post- 
transplant and by looking for the presence of antibodies bound to the grafts. Frozen 
sections of the kidneys were made, and these were directly incubated with fluorescein- 
labeled RAR. There was strong staining of the tubular basement membrane, exactly 
as seen in Fig.  5, showing that not only were the rats producing the kidney-specific 
antibody,  but  that  it was binding  in  vivo to  its target  antigen.  The kidneys of the 
animals in group  1, also taken at  100  d  after grafting, did not  show staining of the 
tubular basement membrane. 
Slight  staining of the glomerular basement membrane was seen in  the kidneys of 
both groups  1 and  2 animals. There was a  distinct  impression that  this glomerular 
staining was stronger in  the kidney-antigen-matched  (group  1)  animals.  If this  is a 
valid observation, it could be the result of antigen competition, and the animals with 
a strong response against the tubular basement membrane might respond less strongly 
against whatever antigens are involved in the glomerular staining. 
Attempts  to Define Alternative Alleles  of the Kidney-specific Alloantigen.  DA anti-LEW 
kidney homogenate serum was directed entirely at autoantigens,  as previously pub- 
lished  (18), so that an alternative allele could not be demonstrated with this immu- 
nization. 
Discussion 
This study establishes that in the DA to LEW strain combination (a) there exists a 
non-MHC-linked  locus  coding  for  a  kidney-specific  alloantigen  that,  in  spite  of 
inducing  strong antibody responses, appears not  to play any role in  graft rejection 
and  (b)  the MHC is the only genetic region of importance for primary kidney graft 
rejection. Although there are a  minimum of six non-MHC-linked loci of importance 
for skin graft rejection in the DA and LEW strains as shown in segregating (DA X 
LEW)F2  populations  (27)  none  of these  seems  to  influence  primary  kidney  graft 
rejection. 
Our assay system was  designed  to  detect  all  kidney-specific antibodies  after im- 
munization with kidney homogenate and after kidney transplantation.  Although the 
kidney-specific antigen detected in the LEW anti-DA immunization seems not to be 
of importance in graft rejection, it remains possible that other kidney-specific alloan- 
tigens were present but did not induce a humoral response. However, if such antigens 
exist and are important in graft rejection, it is clear that these antigens would have to 
be coded for by the MHC region. This would seem to be an unlikely possibility. 
When  immunofluorescence studies were performed to localize the antigen,  it was 
found  to  be present  only on  the  basement  membrane of the  proximal  convoluted 
tubules  and on a  small part of Bowman's capsule of some glomeruli. Antibodies  to 
tubular basement membrane antigens have been detected by immunofluorescence in 
chronically rejecting kidney grafts in  the  DA to LEW  (28)  and  (LEW  X  BN)F1  to 
LEW (29,  30)  strain combinations, which is consistent with the strain distribution of 
the DA allele of the kidney alloantigen (see Table I). Clinically, antibodies to tubular 
basement membrane have been noted in occasional kidney transplant patients ([31- D.  N. J.  HART  AND JOHN  W.  FABRE  663 
36];  and L. C. Paul, L. A. van Es, M. Stuffers-Heiman, G. Brutel de la Riviere, and 
M. W.  Kalff. Antibodies directed against tubular basement  membranes in human 
renal  allograft recipients.  Manuscript  in  preparation.)  and  these would appear  to 
recognize the human homologue of the antigen described in this paper. However, in 
some of the patients, the antibodies reacted with the tubular basement membrane in 
the patient's own kidney, showing that they were not directed at allodeterminants on 
the molecule. Where allospecificity could be shown in the sera  ([31,  35];  and L. C. 
Paul, L. A. van Es, M. Stuffers-Heiman, G. Brutel de la Riviere, and M. W. Kalff. 
Antibodies directed against tubular basement membranes in human renal allograft 
recipients. Manuscript in preparation.), 92-98%  of random kidneys examined were 
positive for the specificity, suggesting that in man, as in the rat, one allele seems to 
predominate. 
In the above-mentioned studies in the rat and man, the MHC linkage of the gene 
responsible for the kidney-specific antigen was not determined, and the role of the 
antigen in graft rejection could not be evaluated. In addition, the use of immunoflu- 
orescence on frozen sections to study the antigen could rmt give any idea of the stength 
of the humoral response to the antigen, nor could precise studies of tissue distribution 
and inter-species cross-reactivity be performed. For example, it is of interest that the 
amount of antibody formed against the kidney-specific alloantigen was roughly equal 
to that against the MHC (Fig.  1). The antigen would appear to be highly immuno- 
genic, because, e.g., LEW anti-DA spleen sera are directed virtually entirely at the 
MHC (24) in spite of there being numerous additional incompatibilities. 
Our species cross-reactivity studies show that a homologous kidney antigen exists in 
the rabbit, in the dog, and in man. The failure of the one guinea pig kidney tested to 
absorb the antibody (Fig. 4) does not exclude the presence of a  homologous antigen 
in the guinea pig. There is no a priori  reason to expect cross-reactivity of the serum 
with homologous antigens of other species.  If cross-reactivity with  the guinea pig 
homologue does exist, the particular animal chosen might fortuitously have expressed 
the less common allele, or different alleles might predominate in the guinea pig. 
We had hoped that the reverse immunization of DA rats with LEW kidney would 
demonstrate an alternative allele of the kidney-specific alloantigen, but no kidney- 
specific alloantibodies could be detected by this immunization (18). This by no means 
excludes the  possibility that  the  antigen system is  allelic.  For example,  the  LEW 
kidney is known to contain large amounts of Ia (RT1-B)  antigens, but the DA rats 
also failed to produce any antibodies to these antigens when immunized with LEW 
kidney (18).  Reverse immunizations do not necessarily produce antibodies to alter- 
native alleles, as is well demonstrated in the rat Ly-1 system (37, 38). 
Studies in progress have shown that the component of the LEW anti-DA kidney 
graft serum which is absorbed by DA spleen (Fig. 1 B) is directed at both RT1-A (SD) 
and RT 1-B (Ia) antigens of the MHC. Thus the antibody response mounted by LEW 
rats to DA kidney grafts consists of four major components directed at (a) a  kidney- 
specific alloantigen;  (b)  a  kidney-specific autoantigen;  (c)  SD-type antigens of the 
MHC; and (d)  Ia-type antigens of the MHC. 
Summary 
The alloantibody response of LEW rats immunized with DA kidney homogenate 
or given vascularized DA kidney grafts was studied using an 12SI-anti-Ig binding assay 664  A KIDNEY-SPECIFIC  ALLOANTIGEN  IN THE  RAT 
with  kidney  homogenate  as  the  target  tissue.  A  major component  of the  sera  was 
found  to  be  directed  at  a  kidney-specific  alloantigen.  Analysis  of LEW  ×  (DA  X 
LEW)Fa backcross rats showed that the locus coding for this antigen was not linked 
to  the  major  histocompatibility  complex  (MHC).  The  use  of these  backcross  rats, 
typed  for both  MHC  and  the  kidney  alloantigen,  as  kidney  donors  to  LEW  rats 
showed that the kidney alloantigen  did not induce detectable graft damage and that 
only the DA MHC  was involved in primary graft rejection of DA kidneys by LEW 
rats. Immunofluorescence studies localized the antigen to the basement membrane of 
proximal  convoluted  tubules,  and  to  some  Bowman's  capsules.  Strain  distribution 
studies showed that only 2 of 11 strains were negative for the allele under study; these 
were  the  LEW  and  AS strains.  Species  cross-reactivity  studies  showed  that  rabbit, 
dog,  and  human  kidneys could  absorb  this  specificity,  although  more weakly  than 
DA kidney. 
Received  for publication 5 November 1979. 
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